Snehal R. Patel
<p>Clinical areas of expertise include heart failure, cardiac transplantation, mechanical circulatory support.</p>
<p>Clinical areas of expertise include heart failure, cardiac transplantation, mechanical circulatory support.</p>
<p>The treatment of all arrhythmias with a special interest in catheter ablation and cardiac resynchronization therapy.</p>
<p>Dr. Palma's past research has focused on the outcomes of catheter ablation and pioneering interventional electrophysiology techniques.</p>
<FONT face=Arial color=#000000> </FONT>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>BOOK CHAPTERS<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>1)<B style="mso-bidi-font-weight: normal"> Palma E </B>and Scheinman, M. 2000. “Treatment of Cardiac Arrhythmias with Catheter-Ablative Techniques.”<SPAN style="mso-spacerun: yes"> </SPAN>In: Alexander RW, Schlant RC, Fuster V, eds<B style="mso-bidi-font-weight: normal">.<SPAN style="mso-spacerun: yes"> </SPAN><I style="mso-bidi-font-style: normal">The Heart (10<SUP>th</SUP> and 11<SUP>th</SUP> editions</I></B><I style="mso-bidi-font-style: normal">)</I>.<SPAN style="mso-spacerun: yes"> </SPAN>New York, NY.<SPAN style="mso-spacerun: yes"> </SPAN>McGraw-Hill.<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>ARTICLES<o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT color=#000000><FONT face=Arial>1)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line">Fisher JD, Kim SG, Ferrick KJ, Gross JN, <B style="mso-bidi-font-weight: normal">Palma EC</B>, Scavin GM.<SPAN style="mso-spacerun: yes"> </SPAN></SPAN></FONT></FONT></FONT></P>
<P class=MsoBodyText2 style="MARGIN-LEFT: 0.25in"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">Simplified Tilt table test protocol with continuous upright position during medication administration and no hydration. </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> <SPAN style="LAYOUT-GRID-MODE: line">2003; 26:451-452<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>2)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Green J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>What is the Mechanism of the Tachycardia?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Cardiov Electrophys</I></B> 2003. 14(4):435-436</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>3)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Vaidya K, Kim S, Gross J, Ferrick K, <B style="mso-bidi-font-weight: normal">Palma E, </B>Furman S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Runaway pulse generator malfunction resulting from undetected battery depletion.<SPAN style="FONT-FAMILY: Tahoma; mso-bidi-font-family: 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B><SPAN style="mso-spacerun: yes"> </SPAN>2002; 25(2):220-222</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>4)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Saxenberg V, Vijayraman P, Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Histopathologic Correlation of Ablation Lesions Guided by Noncontact Mapping in a Patient with Peripartum Cardiomyopathy and Ventricular Tachycardia.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 2001; 24:1812-1815</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>5)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Vijayraman P, Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Sinus node recovery after 25 years of atrial flutter.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B><SPAN style="mso-spacerun: yes"> </SPAN>2001, 24(8): 1295-1296</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>6)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma, E.<SPAN style="mso-spacerun: yes"> </SPAN></B>Therapeutic options in patients with non-sustained ventricular tachycardia and reduced left ventricular ejection fraction.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Current Cardiology Reports</B> 2001 3(3): 219-223. Ed-in-Chief: Valentin Fuster;<SPAN style="mso-spacerun: yes"> </SPAN>Section Editor:<SPAN style="mso-spacerun: yes"> </SPAN>Thierry LeJemtel</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>7)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Vijayraman P, Ferrick K, Gross J, Kim S and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Is this SVT or VT?<SPAN style="mso-spacerun: yes"> </SPAN>An Exception to the rule.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Journal of Interventional Cardiac Electrophysiology</B><SPAN style="mso-spacerun: yes"> </SPAN>2001 March, 5(1):67-70</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><B style="mso-bidi-font-weight: normal"><FONT color=#000000><FONT face=Arial> </FONT></FONT></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><FONT color=#000000><FONT face=Arial>8)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Transition from AV Node Reentry Tachycardia to Atrial Fibrillation Begins in the Pulmonary Veins.<SPAN style="mso-spacerun: yes"> </SPAN></FONT></FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal">Circulation </B>2000<B style="mso-bidi-font-weight: normal"> </B>Aug 22, 102(8): 937</FONT></FONT></P>
<P class=MsoBodyText style="mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>9)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Cui, J, Melman, Y, <B style="mso-bidi-font-weight: normal">Palma E, </B>Fishman G and McDonald T<B style="mso-bidi-font-weight: normal">.<SPAN style="mso-spacerun: yes"> </SPAN></B>Cyclic AMP modulates<SPAN style="mso-spacerun: yes"> </SPAN>the HERG K+ Channel by Dual Pathways.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Curr Biol.</I></B> 2000 Jun 1;10(11):671-674</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>10)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Gross J.<SPAN style="mso-spacerun: yes"> </SPAN>Understanding the mode switching algorithm of the Intermedics Marathon (Invited Review).<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Herzschrittmachertherapie & Elektrophysiologie </I></B>1999 June, 10 (Suppl 2): I/67-71</FONT></FONT></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><FONT face=Arial color=#000000>11)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Antonelli D, Rosenfeld T, Freedberg N, <B style="mso-bidi-font-weight: normal">Palma E</B>, Gross J, Furman S. Insulation lead failure: is it a matter of insulation coating, venous approach, or both? </FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 1998 Feb, 21(2): 418-21</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>12)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>McDonald TV, Yu Z, Ming Z, <B style="mso-bidi-font-weight: normal">Palma E</B>, Meyers M, Wang K, Goldstein SAN,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman GI. A minK-HERG complex regulates the cardiac potassium current <I style="mso-bidi-font-style: normal">I</I><SUB>Kr</SUB>. <B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Nature</I></B> 1997, 388: 289-292 </FONT></FONT><FONT face=Arial color=#000000>13)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The effect of varying atrial sensitivity, AV interval, and detection algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>automatic mode switching. </FONT></FONT><FONT color=#000000><FONT face=Arial><SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 1996, 19(Pt. II): 1734-1739</FONT></FONT></P>
<P class=MsoNormal style="tab-stops: 2.0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="tab-stops: 2.0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-ALIGN: center; tab-stops: 2.0in" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>ABSTRACTS<o:p></o:p></FONT></SPAN></B></P>
<P class=MsoBodyText style="TEXT-INDENT: -4.5pt; tab-stops: .25in; mso-list: none"><FONT color=#000000><FONT face=Arial><SPAN style="mso-tab-count: 3"> </SPAN><SPAN style="mso-tab-count: 2"> </SPAN><SPAN style="mso-tab-count: 2"> </SPAN><SPAN style="mso-tab-count: 1"> </SPAN></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">1)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Vijayaraman P, <B>Palma E</B>, Shepard R, Wood M, and Ellenbogen K.<SPAN style="mso-spacerun: yes"> </SPAN>Intra-atrial conduction block at the mitral and tricuspid annulus along the coronary sinus during radiofrequency catheter ablation.<SPAN style="mso-spacerun: yes"> </SPAN><B><I>Heart Rhythm Journal</I></B> 1 (1S): S230, 2004; Poster Presentation at the Heart Rhythm Society Meetings, San Francisco, CA<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">2)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Kim S, Del Vecchio A, Ferrick K, Fisher J, Gross J, and <B>Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Facilitation of axillary and cephalic vein cannulation by radio-opaque guide wire inserted via antecubital veins before device implantation.<SPAN style="mso-spacerun: yes"> </SPAN><B><I>Heart Rhythm Journal</I></B> 1 (1S): S176, 2004; Oral Presentation at the Heart Rhythm Society Meetings, San Francisco, CA<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">3)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Green J, Bhatt K, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> Mortality of Patients on Dialysis at the time of ICD Implantation.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2003; Oral Presentation at the 3rd International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 12-15, 2003</SPAN></FONT></FONT><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial>4)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Patel A, Chen T, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> Should Clopidogrel Be Discontinued Before Implanting a device?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2003; Oral Presentation at the 3rd International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 12-15, 2003</SPAN></FONT></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>5)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Kim S, Gross J, Ferrick K, Fisher J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Non-contact<SPAN style="mso-spacerun: yes"> </SPAN>Mapping of Right Atrial Activation During Pulmonary Vein Pacing.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Am Coll Cardiol</I></B> 2001. 39 (5 suppl A): 115A. </FONT></FONT><FONT face=Arial color=#000000>Poster Presentation at the American College of Cardiology 49th Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Atlanta, GA, March 17-20, 2001</FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial>6)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Banchs J, Weiner S, Vijayaraman P, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> ICD Mortality In Octagenarians.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2001; 2(1): 114; Poster Presentation at the 2<SUP>nd</SUP> International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 21-24, 2001</SPAN></FONT></FONT></FONT><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>7)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weiner S, Vijayaraman P, Ferrick K, Kim S, Fisher S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>. Is Post-Operative Atrial Fibrillation a Left Atrial Disease?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>2001 24(4 II): 676; Poster Presentation at the NASPE 22nd Annual Scientific Sessions. Boston, MA, May 2-5, 2001</FONT></FONT><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>8)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, Goseki Y, Sparks P, Kinugawa K, Roithinger F, Nakai T, <B style="mso-bidi-font-weight: normal">Palma E</B>, Lesh M, Keung E, Simpson P, and Lee R. Rapid Atrial Pacing Causes Atrial Remodeling and Genetic Reprogramming in a Canine Model of Chronic Atrial Fibrillation.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 2000; 23 (4 Part II): 639. </FONT></FONT><FONT face=Arial color=#000000>Poster Presentation at the NASPE 21st Annual Scientific Sessions. </FONT><FONT face=Arial color=#000000>Washington, DC, May 17-20, 2000</FONT></P>
<P class=MsoBodyText style="TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>9)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, <B style="mso-bidi-font-weight: normal">Palma E</B>, Roithinger F, Kinugawa K, Goseki Y, Sparks P, Lesh M, Keung E, Simpson P, and Lee R.<SPAN style="mso-spacerun: yes"> </SPAN>The Role of Genetic Reprogramming in a Canine Model of Chronic Atrial Fibrillation – Alterations in Gene Expression of Markers of Hypertrophy and Calcium Homeostasis Proteins. </FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Am Coll Cardiol</I></B> 2000. 35 (2 suppl A): 146A</FONT></FONT><FONT face=Arial color=#000000>Oral Presentation at the American College of Cardiology 49th Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Anaheim, CA, March 12-15, 2000</FONT></P>
<P class=MsoBodyText style="TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>10)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, <B style="mso-bidi-font-weight: normal">Palma E</B>, Roithinger F, Gozeki Y, Lesh M, Keung E, Simpson P, Lee R.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Fibrillation in a Chronic Dog Model Alters the Protein Level of the Na/Ca Exchanger and SERCA.</FONT></FONT><FONT color=#000000><FONT face=Arial><FONT size=3><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="mso-tab-count: 1"> </SPAN>Pacing and Clinical Electrophysiology</I></B> 1999; 22 (4 Part II): 726</FONT></FONT></FONT><FONT color=#000000><FONT face=Arial><SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the NASPE 20<SUP>th</SUP> Annual Scientific Sessions. Toronto, Canada May 12-15, 1999</FONT></FONT></P>
<P class=MsoBodyText style="mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>11)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Ming Z, Yu Z,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman G, McDonald TV.<SPAN style="mso-spacerun: yes"> </SPAN>Cyclic-AMP-Dependent Phosphorylation and Regulation of HERG.</FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1998 October 27, 98 (17 Supplement): I-57</SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><SPAN style="mso-tab-count: 1"> </SPAN>Oral Presentation at the American Heart Association 1998 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Dallas, TX, November 8-11, 1998</FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in"><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">12)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Ma T, Keung EC, Gallinghouse GJ, Weyerbrock SW, Long CS, Simpson PC, Lee RJ. Adenoviral Overexpression of SERCA2a Prevents Triggered Activity induced by lnterleukin-1</SPAN><FONT face=Arial><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Symbol; mso-bidi-font-size: 10.0pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">b</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> in Neonatal Rat Myocytes. </SPAN></FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1998 October 27, 98 (17 Supplement): I-415</SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><SPAN style="mso-tab-count: 1"> </SPAN>Poster Presentation at the American Heart Association 1998 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Dallas, TX, November 8-11, 1998<B style="mso-bidi-font-weight: normal"><o:p></o:p></B></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>13)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Keung EC, Simpson PC, Long CS, Lee RJ. Cytokine-Induced Triggered Activity: A New Mechanism of Arrhythmogenesis. </FONT></SPAN><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Pacing and Clinical Electrophysiology</SPAN></I></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1998; 21, 4 (Pt II): 898. </SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>Poster Presentation at the NASPE 19<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>San Diego, CA, May 6-9, 1998<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="tab-stops: 0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 0in .25in"><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">14)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Gallinghouse GJ, Ma T, Keung EC, SImpson PC, Long CS, Lee RJ.<SPAN style="mso-spacerun: yes"> </SPAN>The Effect of Adenoviral Overexpression of SERCA2a on IL-1</SPAN><FONT face=Arial><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Symbol; mso-bidi-font-size: 10.0pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">b</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> Action Potential Prolongation in Neonatal Rat Myocytes. </SPAN></FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Pacing and Clinical Electrophysiology</SPAN></I></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1998; 21, 4 (Pt II): 857. </SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>Featured Poster at the NASPE 19<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>San Diego, CA, May 6-9, 1998<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-INDENT: 0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>15) McDonald T, Ming Z, <B style="mso-bidi-font-weight: normal">Palma E, </B>Yu Z,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman G.<SPAN style="mso-spacerun: yes"> </SPAN>MinK Enhances Functional Expression of HERG-K+ Currents in CHO Cell Co-Transfection Studies. </FONT></SPAN><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1996; 94, 8: I –163.<SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the American Heart Association 1997 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>New Orleans, LA, November 10-13, 1996<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="tab-stops: 0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>16) <B style="mso-bidi-font-weight: normal">Palma E</B>, Andrews C, Hanson S, Cua M, Gross J, Furman S.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Arrhythmias and Survival of the VDD Mode in Single-Lead VDD Pacemakers.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>1996; 19, 4 (II): 636.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation in NASPE 17<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Seattle, WA, May 15-18, 1996<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>17) <B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The Effect of Varying Atrial Sensitivity, AV interval, and Detection Algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>Automatic Mode Switching.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>1996; 19, 4 (II): 636.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation in NASPE 17<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Seattle, WA, May 15-18, 1996<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">INTERNATIONAL ABSTRACTS AND PRESENTATIONS</SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><o:p></o:p></SPAN></FONT></P>
<H2 style="MARGIN-RIGHT: 4.3pt; TEXT-ALIGN: left; tab-stops: 369.0pt" align=left><SPAN style="mso-tab-count: 1"><FONT face=Arial color=#000000 size=3></FONT></SPAN></H2>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in 189.0pt"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>1)<SPAN style="mso-spacerun: yes"> </SPAN>I Stathopoulos, SG Kim, JN Gross, KJ Ferrick, JD Fisher, EC Palma.<SPAN style="mso-spacerun: yes"> </SPAN>Should Antiarrhythmics be stopped after atrial flutter ablation if afib is present?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">European Journal of Cardiac Pacing and Electrophysiology </B>2004 </FONT></SPAN><FONT color=#000000><FONT face=Arial><FONT size=3><SPAN style="mso-spacerun: yes"> </SPAN>Poster presentation at the Cardiostim 2004 14<SUP>th</SUP> International Congress. </FONT></FONT></FONT><FONT face=Arial color=#000000 size=3>Nice, France June 19-22, 2004</FONT></P>
<P class=MsoNormal style="tab-stops: 2.0in 189.0pt"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">2)<SPAN style="mso-spacerun: yes"> </SPAN>A. Lee, SG Kim, JN Gross, KJ Ferrick, JD Fisher, EC Palma</SPAN><FONT face=Arial>. <SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Non-Contact Mapping of Right Atrial Activation During Non-isthmus-dependent Atrial Flutter. <B style="mso-bidi-font-weight: normal">European Journal of Cardiac Pacing and Electrophysiology </B>2002. </SPAN></FONT></FONT><FONT color=#000000><FONT face=Arial><FONT size=3><SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 2002 13<SUP>th</SUP> International Congress. </FONT></FONT></FONT><FONT face=Arial color=#000000 size=3>Nice, France June 19-22, 2002</FONT><FONT color=#000000><FONT face=Arial><FONT size=3> <o:p></o:p></FONT></FONT></FONT></P>
<H2 style="MARGIN: 0in 4.3pt 0pt 0.25in; TEXT-INDENT: -0.25in; TEXT-ALIGN: left; tab-stops: list .25in left 369.0pt; mso-list: l26 level1 lfo25" align=left><FONT face=Arial color=#000000 size=3>2)<SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Kim S, Gross J, Ferrick K, Fisher J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Non-contact Mapping of Right Atrial Activation During Pulmonary Vein Pacing.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Europace</I></B> 2001; 2(suppl C): C13;<SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the 7<SUP>th</SUP> International Workshop on Cardiac Arrhythmias, Venice , Italy<SPAN style="mso-spacerun: yes"> </SPAN>October 7-10, 2001</FONT></H2>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: .25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>3)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Andrews C, Hanson S, Cua M, Gross J, Furman S.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Arrhythmias and Survival of the VDD Mode in Single-Lead VDD Pacemakers.<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in 189.0pt"><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>European Journal of Cardiac Pacing and Electrophysiology </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1996; 6, 1 (Suppl 5):242.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 1996 10<SUP>th</SUP> International Congress.<SPAN style="mso-spacerun: yes"> </SPAN>June 19-22, 1996, Nice, France <B style="mso-bidi-font-weight: normal"><o:p></o:p></B></SPAN></FONT></P>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>4)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The Effect of Varying Atrial Sensitivity, AV interval, and Detection Algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>Automatic Mode Switching.<SPAN style="mso-spacerun: yes"> </SPAN><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -13.5pt; tab-stops: .25in 2.0in 189.0pt"><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>European Journal of Cardiac Pacing and Electrophysiology </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1996; 6, 1 (Suppl 5): 197.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 1996 10<SUP>th</SUP> International Congress.<SPAN style="mso-spacerun: yes"> </SPAN>June 19-22, 1996, Nice, France<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -13.5pt; tab-stops: .25in 2.0in 189.0pt"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<p>Eugen C. Palma, MD, FACC, FHRS, is a Professor of Medicine and the Director of Weiler Arrhythmia Service at Montefiore and our <a href="http://www.einstein.yu.edu/faculty/5316/eugen-palma/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on the treatment of all arrhythmias, with a special interest in catheter ablation and cardiac resynchronization therapy. Dr. Palma joined the Montefiore team in 1999.</p><p>Dr. Palma received his Bachelor of Science in Basic Medical Science in 1986 and his Doctor of Medicine in 1989 at the University of the Philippines in Manila, Philippines. He completed a residency in internal medicine in 1994, becoming Chief Resident in 1993 at the State University of New York at Stony Brook. He then began a fellowship in the Division of Cardiology at Montefiore in 1994. In 1999, Dr. Palma completed a fellowship in Cardiac Electrophysiology at the University of California at San Francisco at the Cardiovascular Research Institute.</p><p>Dr. Palma’s research has focused on the outcomes of catheter ablation and pioneering interventional electrophysiology techniques, including subclavian and coronary sinus venoplasty for cardiac resynchronization therapy. His research has been published in various articles, including “Subclavian Venoplasty May Reduce Implant Times and Implant Failures in the Era of Increasing Device Upgrades” in Pacing and Clinical Electrophysiology and “Coronary Sinus Venoplasty for Optimal Left Ventricular Lead Placement in Cardiac Resynchronization Therapy” in the Journal of Innovations in Cardiac Rhythm Management, as well as numerous peer-reviewed journals and books.</p><p>In 1994, Dr. Palma received the Northport VAMC First Annual Chiefs’ Award for outstanding achievements in laboratory medicine. He is board certified by the American Board of Internal for Clinical Cardiac Electrophysiology,a Fellow of the American College of Cardiology, and a member of the Heart Rhythm Society.</p>
<p>Dr. Robert Ostfeld is the founder and director of the Cardiac Wellness Program at Montefiore, an Associate Professor of Clinical Medicine and Albert Einstein College of Medicine, and the Associate Director of the Cardiology Fellowship at Einstein-Montefiore.</p>
<p>Dr. Ostfeld is the author of over 2 original articles and has authored numerous book chapters, reviews, and clinical statements. His professional interests include cardiovascular disease prevention, medical education, and clinical research. He speaks frequently to both the medical and lay community regarding cardiovascular disease prevention.</p>
<p>Dr. Ostfeld earned the outstanding Full-Time Attending of the Year award at Montefiore for excellence in teaching medical residents, received the Program Director's Award for dedicated service on behalf of the Montefiore Einstein Cardiology Fellowship, and was elected to the Leo M. Davidoff Society at Einstein for outstanding achievement in the teaching of medical residents.</p>
<p><strong>Education</strong></p>
<p>Undergraduate: University of Pennsylvania, 1992. Summa Cum Laude and Phi Beta Kappa </p>
<p>Medical School: Yale University School of Medicine, 1996. </p>
<p>Medical Internship: Massachusetts General Hospital, Harvard Medical School, 1996-1997. </p>
<p>Medical Residency: Massachusetts General Hospital, Harvard Medical School, 1997-1999. </p>
<p>Cardiology Fellowship: Brigham and Women's Hospital, Harvard Medical School, 1999-2003. </p>
<p>Research Fellowship in Preventive Medicine: Brigham and Women's Hospital, Harvard Medical School, 2002-2003. </p>
<p>Master's of Science in Epidemiology: Harvard School of Public Health, 2003. </p>
<p><strong>Clinical Research Interests</strong></p>
<p>Preventive Cardiology, General Cardiology, Valvular Heart Disease, Echocardiography, Medical Education</p>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure.</span>
<p>Robert J. Ostfeld, MD, MSc, FACC, is the Director of Preventive Cardiology at Montefiore Health System and a Professor of Medicine at the Albert Einstein College of Medicine. Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</p><p>Dr. Ostfeld received his Bachelor of Arts in the Biologic Basis of Behavior from the University of Pennsylvania, graduating Summa Cum Laude and Phi Beta Kappa and his Doctor of Medicine from Yale University School of Medicine. He then did his Medical Internship and Residency at the Massachusetts General Hospital and his Cardiology Fellowship and Research Fellowship in Preventive Medicince at Brigham and Women’s Hospital, both teaching hospitals of Harvard Medical School. During his Cardiology Fellowship, he earned a Master’s of Science in Epidemiology from the Harvard School of Public Health.</p><p>Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure. His work has been published in peer-reviewed journals, books, articles, and clinical statements and has been presented nationally.</p><p>Dr. Ostfeld is board certified in Cardiovascular Disease and Echocardiography and he is a member of numerous professional societies, including the Physician’s Committee for Responsible Medicine and the American College of Cardiology. </p>
Dr. Monrads' clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.
Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease.
<p>E. Scott Monrad, MD, CM, is Training Program Director, Cardiovascular Diseases; Director of Cardiovascular Quality; and Vice Chief of Cardiology, Patient Safety and Quality at Montefiore. He is also Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.</p><p>After receiving his Bachelor of Arts from Harvard University in 1975, Dr. Monrad went on to receive his Doctor of Medicine and Master of Surgery in 1979 from McGill University Medical School in Montreal, Quebec. He attended New England Medical Center Hospital for the start of his postdoctoral training, completing an internship in medicine in 1980, and a residency in 1982. From 1982 to 1985, he was a fellow in the cardiovascular division at the Harvard Beth Israel Hospital in Boston, and from 1985 to 1986, he was a research fellow with the cardiology department at Medizinische Poliklinik, Universitaetsspital in Zurich, Switzerland.</p><p>Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease. His research findings have been published in many reviewed journals and abstracts. He has also contributed to many books.</p><p>Dr. Monrad has been included in Castle Connolly Top Doctors. He is board certified and is a member of several professional associations.</p>
<p>Dr. Ulrich Jorde’s laboratory is focused on translational research in advanced heart failure including heart replacement therapy; i.e. durable mechanical circulatory support (left ventricular assist devices/ “artificial hearts”) or cardiac transplantation.</p>
<p>The basis for Dr. Jorde's work is a large clinical program with approximately 2000 heart failure admissions, 35 adult cardiac transplants, and 50 left ventricular assist devices annually. All work is done in close collaboration with cardiothoracic surgical colleagues.</p>
<p>Representative examples of Dr. Jorde’s research include:</p>
<ol>
<li>Investigator initiated mechanistic studies:
<ul type="disc">
<li>Studies of the nasal mucosa vasculature in “pulseless” heart failure patients on continuous-flow LVADs</li>
<li>Hemolysis patterns in CF-LVAD patients and their association with device thrombosis (collaboration with Henny Billett, MD – Hematology)</li>
<li>Reversal of heart failure induced diabetes in CF-LVAD patients</li>
</ul>
</li>
<li>Basic Science Collaborations – Myocardial recovery during mechanical circulatory support (collaboration with Nicholas Frangogiannis, MD)</li>
<li>Outcomes/epidemiology studies – Effect of center volume on survival during heart failure hospital admission</li>
<li>Multicenter studies of investigational mechanical circulatory support devices:
<ul type="disc">
<li>MOMENTUM Trial: A 1200-patient study of long term durable support as bridge to transplantation or destination therapy with the HM III (national PI: Daniel Goldstein, MD)</li>
<li>SHIELD 2: A 452 patient study of acute mechanical circulatory support with the Percutaneous Heart Pump. (national PI: Ulrich Jorde, MD)</li>
</ul>
</li>
</ol>
Specialization in heart failure, cardiac transplantation and mechanical circulatory support for left ventricular assist devices (LVAD); and cardiogenic shock
<ol>
<li>Uriel N, Naka Y, Colombo PC, Farr M, Pak SW, Cotarlan V, Albu JB, Gallagher D, Mancini D, Ginsberg HN, Jorde UP. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail. 2011 Feb;13(2):195-9. </li>
<li>Hirsh B, Mignatti A, Sims DB, Uriel N, Colombo PC, Jorde UP. Effect of beta Blocker Cessation on Chronotropic Incompetence and Exercise Tolerance in Patients with Advanced Heart Failure. Circ Heart Fail. 2012 Sep 1;5(5):560-5.</li>
<li>Uriel N, Morrison K, Garan AR, Kato T, Yuzefpolskaya M, latif F, Restaino S, Mancini DM, Flannery M, Takayama H, John R, Colombo PC, Naka Y, Jorde UP. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous flow left ventricular assist devices: The Columbia Ramp Study. J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75.</li>
<li>Uriel N, Gonzalez-Costello J, Mignatti A, Morrison K, Colombo PC, Jorde UP. Adrenergic Activation Governs Fuel Substrate Availability and Insulin Resistance in Patients with Congestive Heart Failure. J JACC: Heart Failure Vol. 1, Issue 4, Pages 331-337. </li>
<li>Jorde UP , Khushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof D, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ. Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry. J Am Coll Cardiol. 2014 May 6;63(17):1751-7. </li>
<li>Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Costello J, Thomas SS, Han J, Morrison KA, Jones S, Kodali S, Hahn RT, Shames S, Colombo PC, Takayama H, Naka Y. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ HF; Circ Heart Fail. 2014 Mar 1;7(2):310-9.</li>
</ol>
Dr. Hos' clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.
Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings.
<p>Edwin Ho, MD, is Co-Director of the Heart Valve/Structural Heart Center at Montefiore. His clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.</p><p>In 2010, Dr. Ho received his Doctor of Medicine from the University of Toronto in Toronto, Ontario. He continued at the institution for his postdoctoral training with a three-year residency in general internal medicine from 2010 to 2013, followed by a three-year residency in adult cardiology, which he completed in 2016. He then pursued a clinical fellowship in echocardiography, interventional echocardiography and valvular heart disease at St. Michael’s Hospital in Toronto. After completing this in 2017, he continued his postdoctoral training at the University Hospital of Zurich in Switzerland, completing a clinical fellowship in interventional echocardiography and valvular heart disease in 2017 to 2019.</p><p>Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings. He has been an invited manuscript reviewer for <em>Circulation: Cardiovascular Imaging</em> and <em>Cardiovascular Medicine</em>.</p>
<p>Dr. Guttenplan is committed to improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. All contemporary approaches including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices are drawn upon to achieve this aim.</p>
<p>Dr. Guttenplan is the principle investigator at Montefiore in an outcomes study of a left ventricular quadrapolar pacing lead. During the study he as adapted the use of an interventional snare technique. This approach has allowed for successful left ventricular lead placement, that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-investigator in the division's ablation studies.</p>
<p>Nils A. Guttenplan, MD, is an Attending Physician in the Cardiology Department at Montefiore. His clinical focus is improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. He has an interest in all contemporary approaches to achieve this aim, including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices. Dr. Guttenplan joined the Montefiore team in 2018.</p><p>Dr. Guttenplan attended New York Medical College where he received his Doctor of Medicine. In 2004, Dr. Guttenplan completed a residency in Internal Medicine at St. Vincent?s Medical Center. He completed a fellowship in Cardiovascular Disease at our Albert Einstein College of Medicine, followed by a fellowship in Clinical Cardiac Electrophysiology at New York University.</p><p>Dr. Guttenplan is the Principal Investigator in a study on left ventricular quadripolar pacing lead. During the study, he has developed the use of an interventional snare technique that has allowed for successful left ventricular lead placement that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-Investigator in the division's ablation studies. His work has been published in numerous peer-reviewed journals.</p>
<p>Dr. Gross specializes in complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p>
<p>Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p>
<p>Jay N. Gross, MD, serves as an Attending Physician and Director of the Implantable Electrical Devices Service at Montefiore, as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/2274/jay-gross/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p><p>After graduating from our Albert Einstein College of Medicine, and completing his residency at Montefiore in Internal Medicine, Dr. Gross continued on to complete a cardiology fellowship at Montefiore. <br /><br />Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate-modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p><p>Recent clinical highlights for Dr. Gross include: the first reported cases of implantation of subcutaneous ICDs in heart transplant patients, simultaneous lead extraction and debulking of large vegetations in patients with endocarditis, concomitant lead extraction and implantation of leadless pacemakers, and care for of congenital heart patients who require both transvenously implanted devices and subcutaneous ICDs.</p><p>Dr. Gross is board certified in Internal Medicine, Cardiology, and Cardiovascular Electrophysiology as well as a Certified Cardiac Device Specialist (CCDS) by the International Board of Heart Rhythm Examiners. He is a Fellow of the American College of Cardiology and a member of the Heart Rhythm Society. Dr. Gross has served on the Writing Committee of the International Board of Heart Rhythm Board of Examiners for over two decades and now serves on its board of directors. He has been named to the Castle Connolly/NY Magazine List of Best EP Doctors in New York for the past two years.</p>